Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
J ANTIINFECTIVES FOR SYSTEMIC USE
J01 ANTIBACTERIALS FOR SYSTEMIC USE
J01M QUINOLONE ANTIBACTERIALS
J01MA Fluoroquinolones
J01MA18 Pazufloxacin
D05382 Pazufloxacin mesilate (JP18) <JP>
Therapeutic category of drugs in Japan [BR:br08301]
6 Agents against pathologic organisms and parasites
62 Chemotherapeutics
624 Synthetic antibacterials
6241 Pyridonecarboxylic acids
D05382 Pazufloxacin mesilate (JP18)
Drug groups [BR:br08330]
Antibacterial
DG01550 Quinolone
DG01549 Fluoroquinolone
DG00629 Pazufloxacin
D05382 Pazufloxacin mesilate
Metabolizing enzyme inhibitor
DG01634 CYP1A2 inhibitor
DG00629 Pazufloxacin
D05382 Pazufloxacin mesilate
Drug classes [BR:br08332]
Antibacterial
DG01549 Fluoroquinolone
D05382 Pazufloxacin mesilate
Antimicrobials [BR:br08307]
Antibacterials
Nucleic acid synthesis inhibitor
Fluoroquinolone
D05382 Pazufloxacin mesilate (JP18) <JP>
Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
Chemicals
D05382 Pazufloxacin mesilate
D05382 Pazufloxacin mesilate injection
New drug approvals in Japan [br08318.html]
Drugs with new active ingredients
D05382
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D05382
Drug metabolizing enzymes and transporters [br08309.html]
Drug metabolizing enzymes
D05382
Drug groups [BR:br08330]
Antibacterial
DG01550 Quinolone
DG01549 Fluoroquinolone
DG00629 Pazufloxacin
Metabolizing enzyme inhibitor
DG01634 CYP1A2 inhibitor
DG00629 Pazufloxacin
Antimicrobials abbreviations [BR:br08327]
Antibacterials
Nucleic acid synthesis inhibitor
Fluoroquinolone
DG00629 Pazufloxacin